Status | Study |
Active, not recruiting |
Study Name: A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2) Condition: Alopecia Chemotherapy Effects Date: 2016-12-06 Interventions: Other: CG428 The experimental group will receive CG428. For each application, the patient should shake t |
Recruiting |
Study Name: Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata Condition: Alopecia Areata Date: 2016-11-23 Interventions: Drug: PF-06651600 200 mg QD du |
Active, not recruiting |
Study Name: Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study Condition: Androgenic Alopecia Date: 2016-09-19 Interventions: Device: ARTAS System Other: Manual Implant |
Recruiting |
Study Name: Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN) Condition: Alopecia Date: 2016-09-18 Interventions: Drug: CG 428 cutaneous solution |
Recruiting |
Study Name: MLE4901 vs. Placebo for the Treatment of PCOS Condition: Polycystic Ovary Syndrome (PCOS) Date: 2016-08-10 Interventions: Drug: MLE4901 40mg Drug: Placebo |
Recruiting |
Study Name: AGA Biocellular Stem/Stromal Hair Regenerative Study Condition: Hair Disease Date: 2016-07-27 Interventions: Procedure: Intradermal Injection in hair loss |
Completed |
Study Name: Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia Condition: Androgenetic Alopecia Date: 2016-07-26 Interventions: Drug: Bimatoprost 1% Formulation A |
Recruiting |
Study Name: Hairstetics Hair Implant Device Safety and Efficacy Condition: Alopecia Date: 2016-07-07 Interventions: Device: Hairstetics hair implant device |
Not yet recruiting |
Study Name: Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia Condition: Androgenic Alopecia Date: 2016-06-29 Interventions: Drug: DA-4001 H 5% minoxidil / |
Active, not recruiting |
Study Name: Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants Condition: Alopecia Areata Alopecia Totalis Date: 2016-06-21 Interventions: Drug: Tofacitinib ointment Patients with AA (with at least 2 patches of alopecia involving the scalp), A |